(Q40468415)

20 September 2017

1 reference

title

The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension. (English)

1 reference

20 September 2017

Burris JF

1

1 reference

20 September 2017

1 April 1995

1 reference

The Journal of Clinical Pharmacology

20 September 2017

1 reference

20 September 2017

35

1 reference

20 September 2017

4

1 reference

20 September 2017

337-342

1 reference

Angiotensin converting enzyme inhibitors

20 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Haemodynamic Effects of Captopril in Hypertensive Patients: Comparison with Saralasin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Lisinopril in hypertensive patients with and without renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Age and antihypertensive drugs (hydrochlorothiazide, bendroflumethiazide, nadolol and captopril).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Synergistic effect of captopril with hydrochlorothiazide for the treatment of low-renin hypertensive black patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

24-hour blood pressure profiles in hypertensive patients administered ramipril or placebo once daily: Magnitude and duration of antihypertensive effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Circadian variation and triggers of onset of acute cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Effects of combination therapy with captopril and nifedipine in severe or resistant hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Captopril and nifedipine in combination for moderate to severe essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Long-term experience with captopril in severe hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Mood-elevating effect of captopril in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

The effects of antihypertensive therapy on the quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Implications of local angiotensin production in cardiovascular physiology and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Quinapril--a preclinical review of the pharmacology, pharmacokinetics, and toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Converting-enzyme inhibitors in the treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

Slowing the Progression of Diabetic Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1995.TB04070.X

10.1002/J.1552-4604.1995.TB04070.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7650220